<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Electrical stimulation of the rat carotid artery causes a deep medial injury and the formation of a platelet-rich <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Occlusive <z:mp ids='MP_0005048'>thrombosis</z:mp> at sites of vessel wall injury was significantly reduced after the oral administration of <z:chebi fb="0" ids="37941">clopidogrel</z:chebi>, a potent analogue of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>, which showed dose-dependent inhibition of the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation (ED50 = 1.0 +/- 0.2 mg/kg, p.o.) </plain></SENT>
<SENT sid="2" pm="."><plain>Accumulation of thrombotic material was also considerably reduced after the i.v. administration of SR 27417, a highly potent and selective platelet activating factor receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (ED50 = 10 micrograms/kg, i.v.), nafagrel, a <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> synthetase inhibitor (ED50 = 1.3 mg/kg, i.v.) and hirudin (ED50 = 140 micrograms/kg, i.v.) </plain></SENT>
<SENT sid="3" pm="."><plain>A high dose (20 mg/kg, i.v.) of the anti-adhesive <z:chebi fb="0" ids="48030">tetrapeptide</z:chebi> Arg-Gly-Asp-Ser (RGDS) showed only a slight effect on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation whereas aspirin was ineffective </plain></SENT>
<SENT sid="4" pm="."><plain>These results confirm that <z:chebi fb="13" ids="16761">ADP</z:chebi> and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> play key roles in the initiation and progression of arterial <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and suggest that platelet activating factor may also modulate <z:mp ids='MP_0005048'>thrombosis</z:mp> in this experimental model </plain></SENT>
</text></document>